South Africa Antibody Drug Conjugates (ADC) Market to 2032
Overview
The South Africa Antibody Drug Conjugates (ADC) Market is expected to reach a 145.06 USD Million by 2032 and is projected to grow at a CAGR of 15.56% from 2025 to 2032.
Revenue, 2024 (USD Million)
52.70
Forecast, 2032 (USD Million)
145.06
CAGR, 2024 - 2032
15.56%
Report Coverage
South Africa
South Africa Antibody Drug Conjugates (ADC) Market 2018-2032 USD Million
South Africa Antibody Drug Conjugates (ADC) Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 52.70 USD Million
- Projected Market Size (2032): 145.06 USD Million
- CAGR (2025-2032): 15.56%
Key Findings of South Africa Antibody Drug Conjugates (ADC) Market
- The South Africa Antibody Drug Conjugates (ADC) Market was valued at 52.70 USD Million in 2024.
- The South Africa Antibody Drug Conjugates (ADC) Market is likely to grow at a CAGR of 15.56% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Enhertu in Product Segment accounted for the largest share of the market with a revenue of 46.56 USD Million
- The fastest growing segment Ambulatory Centers in End User Segment grew Fastest with a CAGR of 16.76% during the forecast period from 2024 to 2032.
South Africa Antibody Drug Conjugates (ADC) Market Scope
South Africa Antibody Drug Conjugates (ADC) Market Segmentation & Scope
End User
- Home Healthcare
- Others
- Ambulatory Centers
- Clinics
- Specialty Center
- Hospitals
Indication
- Others
- Genitourinary Cancer
- Gastrointestinal Cancer
- Gynecological Cancer
- Lung Cancer
- Blood Cancer (Leukemia, Lymphoma)
- Breast Cancer
Conjugation Technology
- Chemical Conjugation
- Site-Specific Conjugation
Linker Technology
- Disulfide Linkers
- Hydrazone Linkers
- Thioether Linkers
- Peptide Linkers
Distribution Channel
- Others
- Retail Sales
- Direct Tenders
Antigen Component
- Tissue Factors
- CD33
- CD19
- Others
- CD22
- Nectin 4
- CD30
- CD79B
- Trop-2
- HER2 Receptor
Product
- Others
- Tivdak
- Mylotarg
- Zylonta
- Elahere
- Besponsa
- Padcev
- Polivy
- Trodelvy
- Kadcyla
- Adcetris
- Enhertu
Antibody Component
- First Generation ADCs
- Fourth Generation ADCs
- Second Generation ADCs
- Third Generation ADCs
Cytotoxic Payloads or Warheads Component
- Microtubule Disrupting Agents
- DNA Damaging Agents
Linkers Component
- Non Cleavable Linkers
- Cleavable Linkers
South Africa Antibody Drug Conjugates (ADC) Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2023 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 52.70 USD Million |
| Market Value in 2032 | 145.06 USD Million |
| CAGR (2025-2032) | 15.56% |
| Historic Data | 2016-2023 |
| Market Segments Covered | End User,Indication,Conjugation Technology,Linker Technology,Distribution Channel,Antigen Component,Product,Antibody Component,Cytotoxic Payloads or Warheads Component,Linkers Component |
Regional Insights:
-
Leading Market (2024-2032): South Africa, leading in terms of revenue 52.70 USD Million in 2024
- Key Country: South Africa, leading in terms of revenue with value of 52.70 USD Million in 2024.
Segments and Scope
-
South Africa Antibody Drug Conjugates (ADC) Market to 2032, By End User
- Hospitals is the largest segment in South Africa Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 32.83 USD Million in the year 2024.
- Ambulatory Centers is the Fastest growing segment in South Africa Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 15.21 % in forecast period 2025-2032.
-
South Africa Antibody Drug Conjugates (ADC) Market to 2032, By Indication
- Breast Cancer is the largest segment in South Africa Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 24.26 USD Million in the year 2024.
- Breast Cancer is the Fastest growing segment in South Africa Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 16.14 % in forecast period 2025-2032.
-
South Africa Antibody Drug Conjugates (ADC) Market to 2032, By Conjugation Technology
- Site-Specific Conjugation is the largest segment in South Africa Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 31.07 USD Million in the year 2024.
- Site-Specific Conjugation is the Fastest growing segment in South Africa Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 16.00 % in forecast period 2025-2032.
-
South Africa Antibody Drug Conjugates (ADC) Market to 2032, By Linker Technology
- Peptide Linkers is the largest segment in South Africa Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 33.34 USD Million in the year 2024.
- Peptide Linkers is the Fastest growing segment in South Africa Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 15.65 % in forecast period 2025-2032.
-
South Africa Antibody Drug Conjugates (ADC) Market to 2032, By Distribution Channel
- Direct Tenders is the largest segment in South Africa Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 35.99 USD Million in the year 2024.
- Retail Sales is the Fastest growing segment in South Africa Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 15.59 % in forecast period 2025-2032.
-
South Africa Antibody Drug Conjugates (ADC) Market to 2032, By Antigen Component
- HER2 Receptor is the largest segment in South Africa Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 32.72 USD Million in the year 2024.
- HER2 Receptor is the Fastest growing segment in South Africa Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 15.92 % in forecast period 2025-2032.
-
South Africa Antibody Drug Conjugates (ADC) Market to 2032, By Product
- Enhertu is the largest segment in South Africa Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 46.56 USD Million in the year 2024.
- Enhertu is the Fastest growing segment in South Africa Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 15.68 % in forecast period 2025-2032.
-
South Africa Antibody Drug Conjugates (ADC) Market to 2032, By Antibody Component
- Third Generation ADCs is the largest segment in South Africa Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 31.02 USD Million in the year 2024.
- Third Generation ADCs is the Fastest growing segment in South Africa Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 15.72 % in forecast period 2025-2032.
-
South Africa Antibody Drug Conjugates (ADC) Market to 2032, By Cytotoxic Payloads or Warheads Component
- DNA Damaging Agents is the largest segment in South Africa Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 34.23 USD Million in the year 2024.
- DNA Damaging Agents is the Fastest growing segment in South Africa Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 15.64 % in forecast period 2025-2032.
-
South Africa Antibody Drug Conjugates (ADC) Market to 2032, By Linkers Component
- Cleavable Linkers is the largest segment in South Africa Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 42.47 USD Million in the year 2024.
- Cleavable Linkers is the Fastest growing segment in South Africa Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 15.60 % in forecast period 2025-2032.
South Africa Antibody Drug Conjugates (ADC) Market Company Share Analysis
| Company Name |
|
||
| Takeda Pharmaceutical Company Limited | |||
| Astellas Pharma Inc. | |||
| Gilead Sciences, Inc. | |||
| DAIICHI SANKYO COMPANY, LIMITED | |||
| F. Hoffmann-La Roche Ltd. | |||
South Africa Antibody Drug Conjugates (ADC) Market Geographical Sales Distribution, 2018-2032 USD Million
South Africa Antibody Drug Conjugates (ADC) Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The South Africa Antibody Drug Conjugates (ADC) Market is segmented based on Segmentation End User,Indication,Conjugation Technology,Linker Technology,Distribution Channel,Antigen Component,Product,Antibody Component,Cytotoxic Payloads or Warheads Component,Linkers Component.
South Africa Antibody Drug Conjugates (ADC) Market was valued at USD 52.70(Revenue in USD Million) in 2023.
South Africa Antibody Drug Conjugates (ADC) Market is projected to grow at a CAGR of 15.56% during the forecast period of 2024 to 2032.
The Enhertu segment is expected to dominate the South Africa Antibody Drug Conjugates (ADC) Market, holding a largest market share of 46.56 USD Million in 2024
Coming Soon....
South Africa Antibody Drug Conjugates (ADC) Market Scope
South Africa Antibody Drug Conjugates (ADC) Market Segmentation & Scope
End User
- Home Healthcare
- Others
- Ambulatory Centers
- Clinics
- Specialty Center
- Hospitals
Indication
- Others
- Genitourinary Cancer
- Gastrointestinal Cancer
- Gynecological Cancer
- Lung Cancer
- Blood Cancer (Leukemia, Lymphoma)
- Breast Cancer
Conjugation Technology
- Chemical Conjugation
- Site-Specific Conjugation
Linker Technology
- Disulfide Linkers
- Hydrazone Linkers
- Thioether Linkers
- Peptide Linkers
Distribution Channel
- Others
- Retail Sales
- Direct Tenders
Antigen Component
- Tissue Factors
- CD33
- CD19
- Others
- CD22
- Nectin 4
- CD30
- CD79B
- Trop-2
- HER2 Receptor
Product
- Others
- Tivdak
- Mylotarg
- Zylonta
- Elahere
- Besponsa
- Padcev
- Polivy
- Trodelvy
- Kadcyla
- Adcetris
- Enhertu
Antibody Component
- First Generation ADCs
- Fourth Generation ADCs
- Second Generation ADCs
- Third Generation ADCs
Cytotoxic Payloads or Warheads Component
- Microtubule Disrupting Agents
- DNA Damaging Agents
Linkers Component
- Non Cleavable Linkers
- Cleavable Linkers
Frequently Asked Questions
The South Africa Antibody Drug Conjugates (ADC) Market is segmented based on Segmentation End User,Indication,Conjugation Technology,Linker Technology,Distribution Channel,Antigen Component,Product,Antibody Component,Cytotoxic Payloads or Warheads Component,Linkers Component.
South Africa Antibody Drug Conjugates (ADC) Market was valued at USD 52.70(Revenue in USD Million) in 2023.
South Africa Antibody Drug Conjugates (ADC) Market is projected to grow at a CAGR of 15.56% during the forecast period of 2024 to 2032.
The estimated market value of the South Africa Antibody Drug Conjugates (ADC) Market for final year is USD 145.06 (USD Million).
South Africa Antibody Drug Conjugates (ADC) Market Company Profiling
Frequently Asked Questions
The South Africa Antibody Drug Conjugates (ADC) Market is segmented based on Segmentation End User,Indication,Conjugation Technology,Linker Technology,Distribution Channel,Antigen Component,Product,Antibody Component,Cytotoxic Payloads or Warheads Component,Linkers Component.
South Africa Antibody Drug Conjugates (ADC) Market was valued at USD 52.70(Revenue in USD Million) in 2023.
South Africa Antibody Drug Conjugates (ADC) Market is projected to grow at a CAGR of 15.56% during the forecast period of 2024 to 2032.
The estimated market value of the South Africa Antibody Drug Conjugates (ADC) Market for final year is USD 145.06 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.